Back to Journals » Cancer Management and Research » Volume 13

Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

Total article views   HTML views PDF downloads Totals
4,371 Dovepress* 4,002+ 354 4,356
PubMed Central* 369 177 546
Totals 4,371 531 4,902
*Since 14 September 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar